ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1411	National Cancer Institute	Html	en	Lung Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing lung cancer and about research aimed at the prevention of this disease.	lung cancer screening 0.598829 beta-carotene cancer prevention 0.582664 Retinol Efficacy Trial 0.5493 World Cancer Research 0.557661 radiation-induced cancer risk 0.558005 Cancer Statistics Review 0.554669 Engl J Med 0.601423 lung cancer 0.940569 American Cancer Society 0.565044 new cancer cases 0.561841 cancer prevention study 0.562495 Lung cancer deaths 0.600217 Int J Cancer 0.549565 tobacco-specific lung carcinogen 0.591137 lung cancer survival 0.624991 lung cancers 0.566409 smoking-caused lung cancer 0.618173 Natl Cancer Inst 0.828608 increase lung cancer 0.607425 Clin Cancer Res 0.548805 lung cancer risks. 0.611661 et al. 0.610801 women 0.552318 lung cancer burden 0.611188 lung cancer risks 0.615545	Cancer Epidemiol Biomarkers 0.562574 Cancer Research Fund/American 0.55766 PUBMED Abstract 0.579028 cigarette smoking 0.565154 lung cancer rates 0.635876 National Cancer Institute 0.583038 high lung cancer 0.622636 primary lung cancer 0.607733 Abstract 0.640461 lung adenocarcinoma 0.566862 breast cancer 0.562844 5-year lung cancer 0.61828 breast cancer radiotherapy 0.549181 lung cancer. 0.565606 physical activity 0.552389 Carotene Cancer Prevention 0.55106 lung cancer risk 0.779552 Low-dose lung 0.559226 increases lung cancer 0.60774 lung cancer risk. 0.61153 Public Health Service 0.550531 lung cancer mortality 0.61452 lung cancer incidence 0.71571 air pollution 0.563747	CLICK HERE
1431	National Cancer Institute	Html	en	Prostate Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.	cancer risk factors 0.382888 cancer treatment 0.345379 cancer prevention trials 0.393424 prostate cancer prevention 0.528023 cancer protective factor 0.370188 prostate gland 0.401353 Prostate Cancer Events 0.438643 protective factors 0.37428 Cancer Information Service 0.363767 following PDQ summaries 0.363098 PDQ cancer information 0.439164 advanced prostate cancer 0.435515 high-grade prostate cancer 0.447263 Clinical Trials section 0.34275 prevention clinical trials 0.365763 male sex 0.35549 white men 0.343088 men 0.418793 Prevention Editorial Board 0.367822 treatment clinical trials 0.342421 National Cancer Institute 0.410797 clinical trials 0.465084 folic acid 0.367544	cancer information summary 0.404534 fewer prostate cancers 0.434955 Vitamin E Cancer 0.36527 new treatment 0.346999 localized prostate cancer 0.435368 breast cancer prevention 0.361722 Cancer Prevention Trial 0.41435 prostate cancer increases 0.444676 prostate cancer risk 0.48237 cancer patients 0.343751 Cancer Care page 0.358977 cancer risk factor 0.385548 NCI’s PDQ 0.343309 normal prostate growth 0.414243 PDQ summary 0.356651 aggressive prostate cancers 0.429295 NCI PDQ cancer 0.383175 prostate cancer 0.982122 bigger prostate 0.40149 cancer clinical trials 0.368698 risk factors 0.422068 cancer information summaries 0.367063 comprehensive cancer information 0.367142	CLICK HERE
1441	National Cancer Institute	Html	en	Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of adult acute lymphoblastic leukemia.	Italy Leukemia Group 0.492562 bcr-abl tyrosine kinase 0.570934 adults 0.459185 earlier marrow regeneration 0.455938 allogeneic bone marrow 0.517214 acute lymphoid leukemias 0.472448 remission induction 0.47757 Gale RP 0.454812 imatinib mesylate 0.472156 chemotherapy 0.474627 Engl J Med 0.498791 bone marrow transplantation 0.48642 tyrosine kinase inhibitors 0.483263 Rapid marrow ablation 0.456209 acute myeloid leukemia 0.613636 leukemia group 0.516396 Adult Leukemia Study 0.500665 acute lymphocytic leukemia 0.648415 reverse-transcriptase polymerase chain 0.482354 Burkitt leukemia 0.499236 chronic myeloid leukemia 0.493376 remission rate 0.456311 remission induction regimen 0.463491 polymerase chain reaction 0.48041	bone marrow transplant 0.489602 white blood cell 0.478936 different fusion protein 0.477591 chromosomal abnormalities 0.455367 bone marrow biopsy 0.472092 Abstract 0.51225 patients 0.592026 hairy cell leukemia 0.509021 Clin Oncol 0.480632 chronic myelogenous leukemia 0.543537 bone marrow 0.65205 Philadelphia chromosome 0.465482 complete response rate 0.474063 remission induction treatment 0.472074 acute lymphoblastic leukemia 0.938565 complete remission 0.520144 bcr-abl fusion gene 0.592307 acute leukemia 0.555648 complete remission status 0.464197 High complete remission 0.459577 marrow remission 0.460989 bone marrow transplants 0.462002 neutropenic cancer patients 0.462006	CLICK HERE
1587	National Cancer Institute	Html	en	Childhood Rhabdomyosarcoma Treatment (PDQ®)–Patient Version	Treatment of children with rhabdomyosarcoma often includes chemotherapy, radiation therapy, and surgery. Learn about the signs, tests to diagnose, survival, treatment, and clinical trials for children with rhabdomyosarcoma in this expert-reviewed summary.	cancer treatment 0.508808 alveolar tumor 0.397789 tissue 0.446976 body 0.557677 type 0.525643 chemotherapy 0.500597 PDQ cancer information 0.443489 childhood rhabdomyosarcoma 0.648755 stereotaxic radiation therapy 0.400999 embryonal tumor 0.43303 clinical trials 0.703451 rhabdomyosarcoma 0.676649 nearby lymph nodes 0.746635 cancer information summary 0.418411 rhabdomyosarcoma cells 0.404898 clinical trial 0.53997 sentinel lymph node 0.434722 malignant tumor cells 0.470546 body radiation therapy 0.454423 lymph nodes 0.791456 radiation therapy machine 0.400658 radiation therapy 0.98278 beam radiation therapy 0.399186 soft tissue sarcoma 0.440069	treatment 0.729346 wide local excision 0.482565 cancer cells 0.726714 Conformal radiation therapy 0.416835 treatment clinical trials 0.409517 stereotactic body radiation 0.441552 National Cancer Institute 0.429355 spinal cord 0.406531 metastatic rhabdomyosarcoma 0.428908 effects cancer treatment 0.408271 new treatment 0.425898 Intensity-modulated radiation therapy 0.401599 external-beam radiation therapy 0.401022 external radiation therapy 0.507659 primary tumor 0.410338 metastatic tumor 0.420784 Childhood Rhabdomyosarcoma Treatment 0.412835 bone marrow 0.399523 cancer clinical trials 0.406325 interstitial radiation therapy 0.400167 tumor 0.799626 recurrent rhabdomyosarcoma 0.413207 internal radiation therapy 0.435661 cancer 0.935623	CLICK HERE
1608	National Cancer Institute	Html	en	Stomach (Gastric) Cancer Screening (PDQ®)–Patient Version	There is no standard or routine screening test for stomach (gastric) cancer. Stomach (gastric) cancer is not common in the U.S. Learn about tests that have been studied to detect or screen for stomach cancer in this expert-reviewed summary.	PDQ Screening 0.53696 Serum pepsinogen levels 0.476069 cancer treatment 0.489595 better food storage 0.483291 cancer screening methods 0.571194 United States 0.52237 ongoing clinical trials 0.488517 screening tests 0.527906 silver-white metallic compound 0.475608 following PDQ summaries 0.550231 Cancer Information Service 0.528818 PDQ cancer information 0.69988 Prevention Editorial Board 0.538784 treatment clinical trials 0.487954 National Cancer Institute 0.62168 clinical trials 0.622347 PDQ documents 0.494877 test result 0.484679 cancer information summary 0.615581 cancer doctors 0.478532 clinical trial 0.495039 new treatment 0.490527 breast cancer prevention 0.511108	test results 0.482671 risk factors 0.481306 Cancer screening trials 0.577316 false-positive test result 0.478411 cancer patients 0.482925 Cancer Care page 0.515504 PDQ database 0.499197 latest published information 0.490927 PDQ® Screening 0.477124 NCI’s PDQ 0.504099 risk factor 0.478731 PDQ summary 0.519732 cancer symptoms 0.504928 NCI PDQ cancer 0.579122 certain risk factors 0.477251 lower salt intake 0.475762 tests 0.5444 stomach cancer 0.956427 cancer information summaries 0.536975 comprehensive cancer information 0.53624 Upper endoscopy 0.478371 stomach cancer screening 0.661237	CLICK HERE
1635	National Cancer Institute	Html	en	Cancell/Cantron/Protocel (PDQ®)–Patient Version	Expert-reviewed information summary about the use of Cancell/Entelev as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	treatment 0.59635 peer-reviewed scientific journals 0.520434 cancer treatment 0.437142 cancer prevention 0.377301 Complementary Therapies Editorial 0.493039 United States 0.466761 Drug Administration 0.651254 Cancer Information Specialist 0.403618 cancer cells 0.478684 Cancer Information Service 0.547985 liquid mixture Cancell 0.377167 PDQ cancer information 0.676104 Cancer Complementary 0.434191 CAM therapies 0.389658 Cancell 0.664087 treatment clinical trials 0.370761 National Cancer Institute 0.97945 studies 0.373926 clinical trials 0.769435 alternative medicine 0.540927 U.S. Food 0.518657 conventional treatment 0.383649 health care 0.363873 cancer information summary 0.557509	scientific journals 0.541722 alternative cancer therapies 0.42141 Federal Trade Commission 0.393843 National Institutes 0.378494 clinical trial 0.410446 National Center 0.359319 CAM cancer research 0.395503 new treatment 0.357379 breast cancer prevention 0.372403 PDQ health 0.366183 cancer patients 0.43176 Cancer Care page 0.374735 health 0.389384 NCI’s PDQ 0.383229 PDQ summary 0.396491 Integrative Health 0.358164 NCI PDQ cancer 0.499567 cancer information database 0.420231 alternative therapies 0.478182 cancer information summaries 0.420966 Therapies Editorial Board 0.444837 research studies 0.372726 conventional treatments 0.361723	CLICK HERE
1636	National Cancer Institute	Html	en	Cartilage (Bovine and Shark) (PDQ®)–Patient Version	Expert-reviewed information summary about the use of bovine and shark cartilage as a treatment for people with cancer. Note: The information in this summary is no longer being updated and is provided for reference purposes only.	cancer treatment 0.483107 human cancer cells 0.399726 cartilage treatment 0.54785 shark cartilage 0.911115 PDQ cancer information 0.489648 Cancer Complementary 0.397259 lung cancer 0.396037 new blood vessels 0.529873 blood vessel growth 0.688109 clinical trials 0.661965 testing bovine cartilage 0.553086 powdered cartilage products 0.528871 bovine cartilage 0.754583 cancer information summary 0.450971 clinical trial 0.545778 patients 0.414137 randomized clinical trial 0.405563 NCI PDQ cancer 0.409125 cancer information database 0.395004 liquid shark cartilage 0.530016 liquid cartilage products 0.569642 powdered shark cartilage 0.613657 cancer information 0.501779 breast cancer cells 0.394321	shark cartilage products 0.633195 laboratory study 0.408409 cartilage products 0.782377 Complementary Therapies Editorial 0.405419 cancer cells 0.530307 Cancer Information Service 0.450397 preclinical studies 0.47111 cartilage product AE–941/Neovastat 0.510074 dietary supplements 0.394341 National Cancer Institute 0.540172 studies 0.47228 alternative medicine 0.440784 pancreatic cancer cells 0.3965 human cartilage 0.495387 PDQ Cartilage 0.50056 shark cartilage product 0.665863 cartilage 0.96677 animal studies 0.448189 standard cancer treatment 0.405448 alternative therapies 0.399716 cancer information summaries 0.395389 powdered cartilage 0.59313 bovine cartilage product 0.523261 cancer 0.811115	CLICK HERE
1975	National Cancer Institute	Html	es	Etapa final de la vida (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre lo que debe ser el cuidado desde los últimos días hasta las últimas horas de vida, esto incluye los síntomas comunes, dilemas éticos que podrían surgir, y la función que desempeña el oncólogo en proveer cuidados al paciente y su familia durante este tiempo.	palliative care experts 0.23431 with medical care 0.241191 discuss palliative care 0.233699 Symptom Assessment 0.232929 puntaje pps 0.250501 Chisholm G 0.239654 impending death 0.225195 American Cancer Society 0.325883 mioclonía inducida 0.230408 signos tardíos 0.255455 cancer care 0.288204 Cancer Patients Admitted 0.244551 Early palliative care 0.234581 Palliative Care Units 0.231229 cancer patients 0.700067 intensidad promedio 0.222271 Palliative Performance Scale 0.307144 PDQ Delirium 0.245083 respiración cheyne-stokes 0.226557 Symptom Assessment Scale 0.224548 End-of-Life Cancer Care 0.259456 hospitalized patients with 0.234983 patients with 0.788026 determinados pacientes 0.252968 Pain Symptom Manage 0.940988	care cancer 0.276344 delirium hiperactivo 0.272295 Santos R 0.261547 cohort study 0.227764 patients with metastatic 0.238354 Cancer Facts 0.237968 palliative care 0.397902 Morita T 0.262872 end-of-life discussion 0.224231 Hosp Palliat Care 0.228606 critical care setting 0.224616 treating delirium 0.237587 ill adult patients 0.223449 correlations with quality 0.226302 clinical signs 0.22445 canadian tertiary care 0.2263 Intern Med 0.224374 Clin Oncol 0.327109 Bruera E 0.232399 terminal care 0.223061 systematic review 0.239239 medical care 0.24121 spiritual care 0.22381 Care Med 0.223485	CLICK HERE
3963	National Cancer Institute	Html	es	Tratamiento del cáncer de orofaringe (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de orofaringe.	tratamiento.Ciertas formas 0.441948 Neck Cancer 0.50872 siguientes procedimientos 0.637903 corporal estereotáctica 0.73941 estadio iv 0.619806 hormona tiroidea 0.524054 siguientes elementos 0.501559 estadio ii 0.502031 rayos x 0.464154 pequeñas marcas 0.437304 estadio ivc 0.501067 enlace drugs approved 0.605888 orofaringe ayuda 0.523898 aguja fina.Se 0.467807 PDQ Consumo 0.531679	estadio iva 0.502486 vías respiratorias 0.466653 cirujano manipula herramientas 0.481463 pequeñas mejora 0.437701 National Cancer Institute 0.433607 siguientes riesgos 0.427789 Instituto Nacional 0.463265 malla ayuda 0.439384 PDQ Tratamiento 0.485984 Physician Data Query 0.531575 radioterapia hiperfraccionada 0.624557 ganglio linfático mide 0.948968 cáncer.ampliar radioterapia 0.563245 distinta intensidad 0.445146 siguientes sumarios 0.538888	CLICK HERE
4394	National Cancer Institute	Html	null	Blue Ribbon Panel Working Groups	Seven working groups comprised of leading experts from the cancer community have been charged with developing recommendations for the Cancer Moonshot Initiative.			CLICK HERE